The epothilones: New therapeutic agents for castration‐resistant prostate cancer
TB Dorff, ME Gross - The oncologist, 2011 - academic.oup.com
The management of castration‐resistant prostate cancer (CRPC) presents a clinical
challenge because of limitations in efficacy and durability with currently available …
challenge because of limitations in efficacy and durability with currently available …
The epothilones: how pharmacology relates to clinical utility
LB Michaud - Annals of Pharmacotherapy, 2009 - journals.sagepub.com
Objective: To review the pharmacologic properties of a novel class of chemotherapeutic
agents, the epothilones, and to summarize findings from recent clinical trials investigating …
agents, the epothilones, and to summarize findings from recent clinical trials investigating …
Novel therapies in genitourinary cancer: an update
D Chu, S Wu - Journal of Hematology & Oncology, 2008 - Springer
In recent years, new treatment for renal cell carcinoma (RCC) has been a spotlight in the
field of cancer therapeutics. With several emerging agents branded as' targeted therapy'now …
field of cancer therapeutics. With several emerging agents branded as' targeted therapy'now …